GSA Capital Partners’s Invivyd IVVD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$426K Sell
327,464
-49,148
-13% -$90.3K 0.03% 1014
2025
Q4
$930K Sell
376,612
-428,609
-53% -$891K 0.08% 406
2025
Q3
$886K Buy
805,221
+369,891
+85% +$328K 0.07% 470
2025
Q2
$311K Buy
435,330
+242,670
+126% +$172K 0.02% 1230
2025
Q1
$117K Sell
192,660
-269,778
-58% -$242K 0.01% 1477
2024
Q4
$205K Buy
+462,438
New +$360K 0.02% 1402
2024
Q3
Sell
-24,744
Closed -$27K 1810
2024
Q2
$27K Buy
+24,744
New +$54.7K ﹤0.01% 1574
2022
Q2
Sell
-21,505
Closed -$98K 1596
2022
Q1
$98K Buy
+21,505
New +$132K 0.01% 1296

Other funds holding IVVD

GSA Capital Partners's IVVD Position: Q1 2026 in Review

GSA Capital Partners reduced its Invivyd (IVVD) stake by 13% in Q1 2026, selling an estimated $90.3K and leaving 327,464 shares worth $426K. The position accounts for 0.03% of the portfolio, ranked #1014.

GSA Capital Partners first reported a position in IVVD in Q1 2022 and has held it in 8 quarters since. The position peaked at $930K in Q4 2025. 140 funds tracked by Wall St. Rank hold IVVD as of Q1 2026.

  • GSA Capital Partners held 327,464 shares of Invivyd worth $426K as of Q1 2026.
  • GSA Capital Partners sold 49,148 Invivyd shares in Q1 2026, an estimated $90.3K.
  • Invivyd made up 0.03% of GSA Capital Partners's portfolio in Q1 2026, its #1014 holding.
  • GSA Capital Partners first reported a position in Invivyd in Q1 2022 and has held it in 8 quarters since.
  • GSA Capital Partners's Invivyd position peaked at $930K in Q4 2025.
  • 140 funds tracked by Wall St. Rank held Invivyd as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.